Rankings
▼
Calendar
REVB FY 2019 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
REVB
Revelation Biosciences, Inc.
$2M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3,638
Net Income
-$3,638
EPS (Diluted)
$-6.72
Cash Flow
Operating Cash Flow
$0
Free Cash Flow
$0
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$22,671
Total Liabilities
$26,309
Stockholders' Equity
-$3,638
Cash & Equivalents
$0
← Q4 2019
All Quarters
